PATENT CLAIM ANALYSIS

Application Number: 15766426
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "426000"]

Abstract:
The present invention provides a pharmaceutical composition and the like comprising (4-{(3S)-3-[(1R)-1-(naphthalen-1-yl)ethylamino]pyrrolidin-1-yl}phenyl)acetic acid (Compound A) or a pharmacologically acceptable salt thereof and a diluent.

Claim (Index 3):
The pharmaceutical composition of  claim 1 , wherein the diluent is at least one selected from the group consisting of lactose, white sugar, maltose, sucrose, mannitol, sorbitol, erythritol, maltitol, xylitol, glucose, crystalline cellulose, corn starch, potato starch, calcium monohydrogen phosphate, calcium dihydrogen phosphate, sodium dihydrogen phosphate and calcium phosphate.

Metadata:
- Claim Count in Document: 51.0
- Percentile: 91.0
- Lexical Diversity: 1.2973
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14825036', '11527501', '13968776', '12355143', '12161787']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7663229615821144
- 35 USC 102 Novelty (BERT): 0.4886400357599681
- Combined Prediction Score: 0.7385546689998999
- Mean Citation Score: 205.200412
- Max Citation Score: 212.06197000000003
- Similarity Product: 157.73645522367363

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test